ILC THERAPEUTICS LTD

Active Glasgow

Research and experimental development on biotechnology

14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

ILC THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 21 Jun 2012 Active Glasgow, United Kingdom 14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

ALFACYTE LIMITED 21 Jun 2012 — 26 Jul 2019
Accounts Submitted 14 May 2026 Next due 31 Mar 2026 3 months overdue
Confirmation Submitted 14 Jul 2025 Next due 27 Jul 2026 1 month remaining
Net assets £3M £618K 2024 year on year
Total assets £3M £863K 2024 year on year
Total Liabilities £518K £246K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

100 West George Street Glasgow G2 1PP United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for ILC THERAPEUTICS LTD (SC426667), an active life sciences and medical technology company based in Glasgow, United Kingdom. Incorporated 21 Jun 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2024
Type full
Next accounts 30 Jun 2025
Due by 31 Mar 2026 3 months overdue

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£1.95M

Increased by £539.04k (+38%)

Net Assets

£2.67M

Increased by £617.65k (+30%)

Total Liabilities

£518.18k

Increased by £245.72k (+90%)

Turnover

N/A

Employees

14

Decreased by 1 (-7%)

Debt Ratio

16%

Increased by 4 (+33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Jun Year End
2023
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 4Dec 2020Seed, Series A
Investor 1Sept 2021Unknown/Other, Series A, IPO
Investor 3Sept 2021Unknown/Other, Series A, IPO

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 430,097 Shares £9.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Jun 2024106,380£2.50m£23.5
13 Oct 202294,483£2.01m£21.25
2 Sept 2021165,889£3.53m£21.25
27 Nov 202011,952£160k£13.388
27 Nov 202034,415£542k£15.75

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (67)

Scottish Enterprise
24.3%
175,991
Kf Business Ventures Lp (acting By Its General Partner, Kopple Financial, Inc)
22.8%
164,706

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Robert Kopple

American

Active
Notified 13 Oct 2022
Residence United States
DOB March 1944
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Scottish Enterprise

Unknown

Active
Notified 13 Oct 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Scottish Enterprise

Ceased 2 Sept 2021

Ceased

Professor William Howard Stimson

Ceased 24 Apr 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 May 2026AccountsAnnual accounts made up to 30 Jun 2025
22 Dec 2025OfficersTermination of Christopher Thomas Wardhaugh as director on 15 Dec 2025
16 Dec 2025AddressChange Registered Office Address Company With Date Old Address New Address
14 Jul 2025Confirmation StatementConfirmation statement made on 13 Jul 2025 with no updates
31 Jan 2025AccountsAnnual accounts made up to 30 Jun 2024
14 May 2026 Accounts

Annual accounts made up to 30 Jun 2025

22 Dec 2025 Officers

Termination of Christopher Thomas Wardhaugh as director on 15 Dec 2025

16 Dec 2025 Address

Change Registered Office Address Company With Date Old Address New Address

14 Jul 2025 Confirmation Statement

Confirmation statement made on 13 Jul 2025 with no updates

31 Jan 2025 Accounts

Annual accounts made up to 30 Jun 2024

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

3 weeks ago on 14 May 2026

Termination of Christopher Thomas Wardhaugh as director on 15 Dec 2025

5 months ago on 22 Dec 2025

Change Registered Office Address Company With Date Old Address New Address

5 months ago on 16 Dec 2025

Confirmation statement made on 13 Jul 2025 with no updates

11 months ago on 14 Jul 2025

Annual accounts made up to 30 Jun 2024

1 years ago on 31 Jan 2025